Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jan;93(1):168-175.
doi: 10.1038/s41390-022-02063-2. Epub 2022 Apr 12.

Neuromonitoring, neuroimaging, and neurodevelopmental follow-up practices in neonatal congenital heart disease: a European survey

Affiliations

Neuromonitoring, neuroimaging, and neurodevelopmental follow-up practices in neonatal congenital heart disease: a European survey

Maria Feldmann et al. Pediatr Res. 2023 Jan.

Abstract

Background: Brain injury and neurodevelopmental impairment remain a concern in children with complex congenital heart disease (CHD). A practice guideline on neuromonitoring, neuroimaging, and neurodevelopmental follow-up in CHD patients undergoing cardiopulmonary bypass surgery is lacking. The aim of this survey was to systematically evaluate the current practice in centers across Europe.

Methods: An online-based structured survey was sent to pediatric cardiac surgical centers across Europe between April 2019 and June 2020. Results were summarized by descriptive statistics.

Results: Valid responses were received by 25 European centers, of which 23 completed the questionnaire to the last page. Near-infrared spectroscopy was the most commonly used neuromonitoring modality used in 64, 80, and 72% preoperatively, intraoperatively, and postoperatively, respectively. Neuroimaging was most commonly performed by means of cranial ultrasound in 96 and 84% preoperatively and postoperatively, respectively. Magnetic resonance imaging was obtained in 72 and 44% preoperatively and postoperatively, respectively, but was predominantly reserved for clinically symptomatic patients (preoperatively 67%, postoperatively 64%). Neurodevelopmental follow-up was implemented in 40% of centers and planned in 24%.

Conclusions: Heterogeneity in perioperative neuromonitoring and neuroimaging practice in CHD in centers across Europe is large. The need for neurodevelopmental follow-up has been recognized. A clear practice guideline is urgently needed.

Impact: There is large heterogeneity in neuromonitoring, neuroimaging, and neurodevelopmental follow-up practices among European centers caring for neonates with complex congenital heart disease. This study provides a systematic evaluation of the current neuromonitoring, neuroimaging, and neurodevelopmental follow-up practice in Europe. The results of this survey may serve as the basis for developing a clear practice guideline that could help to early detect and prevent neurological and neurodevelopmental sequelae in neonates with complex congenital heart disease.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Map plot illustrating the distribution of the 25 European sites that provided a valid questionnaire response.
Fig. 2
Fig. 2. Number of pediatric/neonatal cardiac surgeries.
Bar plot illustrating the distribution of yearly number of (a) pediatric and (b) neonatal cardiac surgeries at the responding centers.
Fig. 3
Fig. 3. Use of pre- and postoperative neuromonitoring and neuroimaging tools.
Bar plot showing the percentages of preoperatively and postoperatively used neuromonitoring and neuroimaging tools. aEEG amplitude-integrated electroencephalography, NIRS near-infrared spectroscopy, EEG electroencephalography, CT computer tomography, CUS cranial ultrasound, MRI magnetic resonance imaging.
Fig. 4
Fig. 4. Use of pre- and postoperative MRI.
Alluvial diagram illustrating the indication and mode of sedation/performance of preoperatively and postoperatively obtained cerebral magnetic resonance images (MRI). *As indicated: modality depends on the clinical condition.

References

    1. Dolk H, Loane M, Garne E. Congenital heart defects in Europe: prevalence and perinatal mortality, 2000 to 2005. Circulation. 2011;123:841–849. doi: 10.1161/CIRCULATIONAHA.110.958405. - DOI - PubMed
    1. van der Bom T, et al. The changing epidemiology of congenital heart disease. Nat. Rev. Cardiol. 2011;8:50–60. doi: 10.1038/nrcardio.2010.166. - DOI - PubMed
    1. Marino BS, et al. Neurodevelopmental outcomes in children with congenital heart disease: evaluation and management: a Scientific Statement from the American Heart Association. Circulation. 2012;126:1143–1172. doi: 10.1161/CIR.0b013e318265ee8a. - DOI - PubMed
    1. Latal B. Neurodevelopmental outcomes of the child with congenital heart disease. Clin. Perinatol. 2016;43:173–185. doi: 10.1016/j.clp.2015.11.012. - DOI - PubMed
    1. Marelli A, Miller SP, Marino BS, Jefferson AL, Newburger JW. Brain in congenital heart disease across the lifespan: the cumulative burden of injury. Circulation. 2016;133:1951–1962. doi: 10.1161/CIRCULATIONAHA.115.019881. - DOI - PMC - PubMed

Publication types